These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1404131)

  • 81. Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target?
    Cawston T
    Ann Rheum Dis; 1993 Nov; 52(11):769-70. PubMed ID: 8250606
    [No Abstract]   [Full Text] [Related]  

  • 82. Effect of intrauterine administration of tetracyclines on cynomolgus monkeys.
    Dubin NH; Parmley TH; Ghodgaonkar RB; Strandberg JD; Rosenshein NB; King TM
    Contraception; 1984 Jun; 29(6):561-71. PubMed ID: 6432434
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines.
    Greenwald RA
    Ann N Y Acad Sci; 1994 Sep; 732():181-98. PubMed ID: 7978790
    [No Abstract]   [Full Text] [Related]  

  • 84. Matrix metalloproteinase inhibitors in the treatment of arthritis: comment on the article by Vincenti et al.
    Greenwald RA
    Arthritis Rheum; 1995 Apr; 38(4):574-5. PubMed ID: 7718015
    [No Abstract]   [Full Text] [Related]  

  • 85. Metalloproteinase inhibitors--crystal gazing for a future therapy?
    Cawston T
    Br J Rheumatol; 1991 Aug; 30(4):242-4. PubMed ID: 1863818
    [No Abstract]   [Full Text] [Related]  

  • 86. Tissue distribution and effects on mitochondrial protein synthesis of tetracyclines after prolonged continuous intravenous administration to rats.
    van den Bogert C; Kroon AM
    Biochem Pharmacol; 1981 Jun; 30(12):1706-9. PubMed ID: 7271857
    [No Abstract]   [Full Text] [Related]  

  • 87. Tetracyclines may be therapeutically beneficial in rheumatoid arthritis.
    Greenwald RA
    J Clin Rheumatol; 1995 Jun; 1(3):185-9. PubMed ID: 19077974
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tetracycline: from antibiotic to antisepsis.
    Bar-Or D; Melamed I
    Crit Care Med; 2005 Jul; 33(7):1660-1. PubMed ID: 16003088
    [No Abstract]   [Full Text] [Related]  

  • 89. Modifications of the urinary volume and osmoluria caused by low doses of tetracyclines in rats.
    Boada JN; Feria M; Padrón F
    Arch Farmacol Toxicol; 1975 Aug; 1(2):185-8. PubMed ID: 1230032
    [No Abstract]   [Full Text] [Related]  

  • 90. [THE DEVELOPMENT OF THE OSSEOUS TISSUE IN NORMAL AND OSTEOPOROTIC SUBJECTS STUDIED WITH TETRACYCLINES].
    BERTELLI G; GENNARI C
    Minerva Med; 1963 Dec; 54():3948-52. PubMed ID: 14125299
    [No Abstract]   [Full Text] [Related]  

  • 91. Tetracycline-induced fixed drug eruptions: influence of dose and structure of tetracyclines.
    Chan HL; Wong SN; Lo FL
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):302-4. PubMed ID: 2931458
    [No Abstract]   [Full Text] [Related]  

  • 92. [Czechoslovak and foreign tetracycline preparation levels in incisors of rats].
    Marhan J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1975; 18(4):741-4. PubMed ID: 1071842
    [No Abstract]   [Full Text] [Related]  

  • 93. Minocycline: far beyond an antibiotic.
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Br J Pharmacol; 2013 May; 169(2):337-52. PubMed ID: 23441623
    [TBL] [Abstract][Full Text] [Related]  

  • 94. What is behind the non-antibiotic properties of minocycline?
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Pharmacol Res; 2013 Jan; 67(1):18-30. PubMed ID: 23085382
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.
    Hasbum A; Quintanilla J; Jr JAA; Ding MH; Levy A; Chew SA
    Future Med Chem; 2021 Feb; 13(4):393-418. PubMed ID: 33399488
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reconsidering the Use of Minocycline in the Preliminary Treatment Regime of Rheumatoid Arthritis.
    Heydari-Kamjani M; Demory Beckler M; Kesselman MM
    Cureus; 2019 Aug; 11(8):e5351. PubMed ID: 31608186
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Subantimicrobial Dose Doxycycline Worsens Chronic Arthritis-Induced Bone Microarchitectural Alterations in a Mouse Model: Role of Matrix Metalloproteinases?
    Horváth Á; Botz B; Kiss T; Csekő K; Kiss I; Felinger A; Szabados T; Kenyeres É; Bencsik P; Mócsai A; Ferdinandy P; Helyes Z
    Front Pharmacol; 2019; 10():233. PubMed ID: 30949048
    [No Abstract]   [Full Text] [Related]  

  • 99. Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity.
    Uchimura T; Nakamura DS; Link EM; Noguchi Y; Ōmura S; Sunazuka T; Greenblatt DJ; Zeng L
    Biochem Pharmacol; 2019 Jul; 165():79-90. PubMed ID: 30862504
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.